Cargando…

A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus

Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinmei, Li, Baofeng, Xu, Jin, Wang, Huimin, Gao, Qingzu, Ye, Feng, Xu, Yuting, Wu, Shuhua, Cheng, Shuqiong, Lu, Yinghao, Guan, Jian, Chen, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950340/
https://www.ncbi.nlm.nih.gov/pubmed/36844617
http://dx.doi.org/10.3892/ol.2023.13718
_version_ 1784893141556396032
author Li, Jinmei
Li, Baofeng
Xu, Jin
Wang, Huimin
Gao, Qingzu
Ye, Feng
Xu, Yuting
Wu, Shuhua
Cheng, Shuqiong
Lu, Yinghao
Guan, Jian
Chen, Bei
author_facet Li, Jinmei
Li, Baofeng
Xu, Jin
Wang, Huimin
Gao, Qingzu
Ye, Feng
Xu, Yuting
Wu, Shuhua
Cheng, Shuqiong
Lu, Yinghao
Guan, Jian
Chen, Bei
author_sort Li, Jinmei
collection PubMed
description Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system of Nanfang Hospital of Southern Medical University between January 2000 and June 2020. It searched the keyword ‘n-ITAC’ and selected pathology. A total of 15 consecutive patients were searched. Finally, the present study analyzed a total of 12 n-ITAC patients. The follow-up time was 47 months on average. For low-grade (G1) tumors, 1 and 3-year overall survival (OS) rate were 100 and 85.7% respectively, while for high-grade (G3) tumors, 1 and 3-year OS rates were 80.0 and 20.0% respectively. Pathological grade may be an adverse prognostic factor (P=0.077). The OS of the surgery group was significantly superior to that of the non-surgery group (3-year OS was 63.6 vs. 0%, P=0.0009). Surgery is an indispensable means of treatment. The OS of patients with positive incisal margin was lower compared with that of patients with negative margin (P=0.186), suggesting that complete resection may be one of the prognostic factors. Patients with high risk factors received radiotherapy. The radiation dose was 66–70 Gy/33F for patients with positive margin or non-operation and was 60 Gy/28F for those with negative margin. Most of the patients received prophylactic irradiation of cervical area. Therefore, the prognosis of pathological high-grade n-ITAC is poor. Surgery is the most effective and an indispensable treatment for n-ITAC. For patients with high risk factors, surgery combined with radiotherapy may be a reasonable treatment. With regard to the cover range of radiotherapy, the primary tumor combined with lymph node drainage area is often used in Nanfang Hospital of Southern Medical University and the total dose of radiotherapy can be reduced if the surgical margin is negative.
format Online
Article
Text
id pubmed-9950340
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-99503402023-02-25 A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus Li, Jinmei Li, Baofeng Xu, Jin Wang, Huimin Gao, Qingzu Ye, Feng Xu, Yuting Wu, Shuhua Cheng, Shuqiong Lu, Yinghao Guan, Jian Chen, Bei Oncol Lett Articles Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system of Nanfang Hospital of Southern Medical University between January 2000 and June 2020. It searched the keyword ‘n-ITAC’ and selected pathology. A total of 15 consecutive patients were searched. Finally, the present study analyzed a total of 12 n-ITAC patients. The follow-up time was 47 months on average. For low-grade (G1) tumors, 1 and 3-year overall survival (OS) rate were 100 and 85.7% respectively, while for high-grade (G3) tumors, 1 and 3-year OS rates were 80.0 and 20.0% respectively. Pathological grade may be an adverse prognostic factor (P=0.077). The OS of the surgery group was significantly superior to that of the non-surgery group (3-year OS was 63.6 vs. 0%, P=0.0009). Surgery is an indispensable means of treatment. The OS of patients with positive incisal margin was lower compared with that of patients with negative margin (P=0.186), suggesting that complete resection may be one of the prognostic factors. Patients with high risk factors received radiotherapy. The radiation dose was 66–70 Gy/33F for patients with positive margin or non-operation and was 60 Gy/28F for those with negative margin. Most of the patients received prophylactic irradiation of cervical area. Therefore, the prognosis of pathological high-grade n-ITAC is poor. Surgery is the most effective and an indispensable treatment for n-ITAC. For patients with high risk factors, surgery combined with radiotherapy may be a reasonable treatment. With regard to the cover range of radiotherapy, the primary tumor combined with lymph node drainage area is often used in Nanfang Hospital of Southern Medical University and the total dose of radiotherapy can be reduced if the surgical margin is negative. D.A. Spandidos 2023-02-14 /pmc/articles/PMC9950340/ /pubmed/36844617 http://dx.doi.org/10.3892/ol.2023.13718 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Jinmei
Li, Baofeng
Xu, Jin
Wang, Huimin
Gao, Qingzu
Ye, Feng
Xu, Yuting
Wu, Shuhua
Cheng, Shuqiong
Lu, Yinghao
Guan, Jian
Chen, Bei
A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title_full A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title_fullStr A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title_full_unstemmed A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title_short A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
title_sort retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950340/
https://www.ncbi.nlm.nih.gov/pubmed/36844617
http://dx.doi.org/10.3892/ol.2023.13718
work_keys_str_mv AT lijinmei aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT libaofeng aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT xujin aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT wanghuimin aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT gaoqingzu aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT yefeng aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT xuyuting aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT wushuhua aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT chengshuqiong aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT luyinghao aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT guanjian aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT chenbei aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT lijinmei retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT libaofeng retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT xujin retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT wanghuimin retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT gaoqingzu retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT yefeng retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT xuyuting retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT wushuhua retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT chengshuqiong retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT luyinghao retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT guanjian retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus
AT chenbei retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus